These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 37295666

  • 1. S1PR1 attenuates pulmonary fibrosis by inhibiting EndMT and improving endothelial barrier function.
    Xiong W, Chen S, Xiang H, Zhao S, Xiao J, Li J, Liu Y, Shu Z, Ouyang J, Zhang J, Liu H, Wang X, Zou H, Chen Y, Chen A, Lu H.
    Pulm Pharmacol Ther; 2023 Aug; 81():102228. PubMed ID: 37295666
    [Abstract] [Full Text] [Related]

  • 2. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY, Kim DY, Yoon JY, Son ES, Kim YJ, Park JW, Jeong SH.
    BMC Pharmacol Toxicol; 2018 Apr 02; 19(1):13. PubMed ID: 29609658
    [Abstract] [Full Text] [Related]

  • 3. Forsythoside A regulates pulmonary fibrosis by inhibiting endothelial-to-mesenchymal transition and lung fibroblast proliferation via the PTPRB signaling.
    Zhang Q, Zhang B, Yang F, Hu Y, Fan R, Wang M, Chen S.
    Phytomedicine; 2024 Jul 25; 130():155715. PubMed ID: 38788399
    [Abstract] [Full Text] [Related]

  • 4. Crosstalk between endothelial cell-specific calpain inhibition and the endothelial-mesenchymal transition via the HSP90/Akt signaling pathway.
    Sun X, Sun Y, Jiang P, Qi G, Chen X.
    Biomed Pharmacother; 2020 Apr 25; 124():109822. PubMed ID: 31958767
    [Abstract] [Full Text] [Related]

  • 5. CXCR7 attenuates the TGF-β-induced endothelial-to-mesenchymal transition and pulmonary fibrosis.
    Guan S, Zhou J.
    Mol Biosyst; 2017 Sep 26; 13(10):2116-2124. PubMed ID: 28820530
    [Abstract] [Full Text] [Related]

  • 6. Selpercatinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
    Li S, Liu Z, Jiao X, Gu J, Liu Z, Meng L, Li W, Zhang T, Liu J, Chai D, Liu J, Yang Z, Liu Y, Jiao R, Li X, Zhou H, Zhang Y.
    Biochem Pharmacol; 2024 Jul 26; 225():116282. PubMed ID: 38762147
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 18β-glycyrrhetinic acid ameliorates bleomycin-induced idiopathic pulmonary fibrosis via inhibiting TGF-β1/JAK2/STAT3 signaling axis.
    Bai Y, Gao L, Han T, Liang C, Zhou J, Liu Y, Guo J, Wu J, Hu D.
    J Steroid Biochem Mol Biol; 2024 Oct 26; 243():106560. PubMed ID: 38917955
    [Abstract] [Full Text] [Related]

  • 11. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F, Mou C.
    Med Sci Monit; 2020 Feb 05; 26():e919739. PubMed ID: 32019905
    [Abstract] [Full Text] [Related]

  • 12. TGF-β1-induced SMAD2/3/4 activation promotes RELM-β transcription to modulate the endothelium-mesenchymal transition in human endothelial cells.
    Jiang Y, Zhou X, Hu R, Dai A.
    Int J Biochem Cell Biol; 2018 Dec 05; 105():52-60. PubMed ID: 30120989
    [Abstract] [Full Text] [Related]

  • 13. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
    Gao L, Jiang D, Geng J, Dong R, Dai H.
    Exp Physiol; 2019 Dec 05; 104(12):1942-1951. PubMed ID: 31535412
    [Abstract] [Full Text] [Related]

  • 14. SIRT1 activation attenuates cardiac fibrosis by endothelial-to-mesenchymal transition.
    Liu ZH, Zhang Y, Wang X, Fan XF, Zhang Y, Li X, Gong YS, Han LP.
    Biomed Pharmacother; 2019 Oct 05; 118():109227. PubMed ID: 31351433
    [Abstract] [Full Text] [Related]

  • 15. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
    Duan FF, Barron G, Meliton A, Mutlu GM, Dulin NO, Schuger L.
    Am J Respir Cell Mol Biol; 2019 Feb 05; 60(2):221-231. PubMed ID: 30230348
    [Abstract] [Full Text] [Related]

  • 16. Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway.
    Gu S, Liang J, Zhang J, Liu Z, Miao Y, Wei Y, Li S, Gu J, Cui Y, Xiao T, Li X, Yang C.
    Molecules; 2023 Feb 27; 28(5):. PubMed ID: 36903446
    [Abstract] [Full Text] [Related]

  • 17. Endothelial-specific Loss of IFT88 Promotes Endothelial-to-Mesenchymal Transition and Exacerbates Bleomycin-induced Pulmonary Fibrosis.
    Singh S, Adam M, Matkar PN, Bugyei-Twum A, Desjardins JF, Chen HH, Nguyen H, Bazinet H, Michels D, Liu Z, Mebrahtu E, Esene L, Joseph J, Ehsan M, Qadura M, Connelly KA, Leong-Poi H, Singh KK.
    Sci Rep; 2020 Mar 11; 10(1):4466. PubMed ID: 32161282
    [Abstract] [Full Text] [Related]

  • 18. MiR-200a modulates TGF-β1-induced endothelial-to-mesenchymal shift via suppression of GRB2 in HAECs.
    Zhang H, Hu J, Liu L.
    Biomed Pharmacother; 2017 Nov 11; 95():215-222. PubMed ID: 28846982
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. APELIN-13 AMELIORATES LPS-INDUCED ENDOTHELIAL-TO-MESENCHYMAL TRANSITION AND POST-ACUTE LUNG INJURY PULMONARY FIBROSIS BY SUPPRESSING TRANSFORMING GROWTH FACTOR-Β1 SIGNALING.
    Liu H, Shi Q, Tang L, Wang H, Wang D.
    Shock; 2023 Jan 01; 59(1):108-117. PubMed ID: 36377383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.